Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion type Assertion NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_head.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion description "[From a practical point of view, they make the combined screening of HLA class II and TAP2 loci a highly valuable tool in IDDM prediction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_provenance.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion evidence source_evidence_literature NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_provenance.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion SIO_000772 8344340 NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_provenance.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion wasDerivedFrom befree-20140225 NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_provenance.
- NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_assertion wasGeneratedBy ECO_0000203 NP651618.RAdOPDU9twKFpJac9KS4RLOjPco7_-gRj9_VpUQUEpteg130_provenance.